LAS VEGAS — In this Healio Video Perspective from Clinical Trials at the Summit, Michael A. Singer, MD, shares the results of a phase 2a trial investigating ANXV, a phosphatidylserine blocker designed to treat retinal vein occlusion.The 13 patients who…
Second Global Consensus on Keratoconus highlighted
COPENHAGEN, Denmark — The Second Global Consensus on Keratoconus and Ectatic Diseases offers a series of practice-shaping updates, with new positions on pediatric treatment, progression criteria and re-treatment strategies.“The field of keratoconus has…
Building moral courage among women in medicine
Moral courage is the strength to speak up even when doing so may have negative consequences. This is vital skill in health care that leads to better organizational culture and better patient outcomes.Fortunately, according to Lauren Weber, MD, FACC, CE…
Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote “AGAINST” Proposed Acquisition by Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) today announced that …
Can Metformin Protect Against Macular Degeneration?
Use of metformin does not appear to be associated with the development or progression of age-related macular degeneration, a study finds. Medscape Medical News
Patients report spectacle independence with PureSee IOL
COPENHAGEN, Denmark — Patients achieved high levels of spectacle independence with the Tecnis PureSee IOL, according to a study presented at the European Society of Cataract and Refractive Surgeons meeting.Oliver Findl, MD, MBA, FEBO, of Vienna Hanusch…